Abstract
Objective: To identify, based on current literature, relevant clinical and therapeutic information regarding the main advances and perspectives in the treatment of pemphigus vulgaris (PV) and pemphigus foliaceus (PF).
Methods: Integrative literature review following the method proposed by Souza et al. (2010), with searches conducted in BVS, SciELO, PubMed, and Google Scholar databases. Articles published between 2015 and 2025, in Portuguese, English, or Spanish, addressing therapeutic options and biopsychosocial impacts of both conditions were included. After screening, 20 studies comprised the final sample. Data were extracted using a standardized form and critically analyzed regarding relevance and methodological quality.
Results: Cyclophosphamide and azathioprine are commonly used in pulse therapy for PV. Rituximab plays a significant role in the treatment of both PV and PF, as does methotrexate, along with other options such as intravenous immunoglobulin. Conclusion: Patient management should be individualized, with careful consideration of mental health and emphasis on cancer screening. A significant gap remains in the literature concerning the most effective therapeutic strategies for both variants, especially for endemic PF, which is prevalent in South America and still underrepresented in robust studies.
References
AOKI V, et al. Update on Fogo Selvagem, an Endemic Form of Pemphigus Foliaceus. The Journaul of Dermatology, 2015; 42(1).
BARCELOS VM, et al. Estudo epidemiológico e clínico dos casos de pênfigo foliáceo endêmico e pênfigo vulgar em centro de referência no estado de Minas Gerais, Brasil. Anais Brasileiros de Dermatologia. 2024; 99(1): 43-52.
BOZA OREAMUNO YV, QUESADA JG. Pénfigo vulgar y su manejo integral: reporte de dos casos y revisión de literatura. International Journal of Dental Sciences, 2022; 24-3.
CARVER CA, et al. Current biologics in treatment of pemphigus foliaceus: a systemati review. Frontier in Immunology, 2023; 14:1267668.
ENNO S, et al. Pemphigus. Lancet. 2019; 394(10201).
FERREIRA JP, et al. Pênfigo: uma revisão narrativa elucidando suas principais características clínicas e o impacto oculto na qualidade de vida dos pacientes. Revista Contemporânea, 2024; 7(4).
FLIEGNER TF, et al. Patogênese, manifestações clínicas e diagnóstico do pênfigo. Brazilian Journal of Implantology and Health Sciences, 2024; 6(11).
FREIRE MLF, et al. Comorbidades associadas e qualidade de vida em pacientes com pênfigo foliáceo e pênfigo vulgar. Revista Eletrônica Acervo Saúde, 2025; 25.
FREITAS GB, et al. Descrição de tratamento para pênfigo vulgar: relato de caso. Archives of Health Investigation, 2021; 10(5).
IIDA S, et al. Improvement of acute phase symptoms of pemphigus foliaceus with spesolimab. JAAD Case Reports, 2025; 55(40-4).
KUCUKOGLU R, et al. A transição entre subtipos de pênfigo é possível? Série de pacientes com pênfigo vulgar apresentando transição para pênfigo foliáceo. Anais Brasileiros de Dermatologia, 2023; 98 (6).
LIU L, et al. Invasive breast cancer found in a new-onset pemphigus foliaceus. JAAD Case Reports, 2021; 18 (67-70).
LUO Y, et al. Epidemiology of malignant tumors in patients with pemphigus: na analysis of trends from 1955 to 2021. Clinical and Experimental Medicine, 2024; 24(1).
MATTHEWS R, ALI Z. Co-morbid Mental Health Issues in Patients with Pemphigus Vulgaris and Pemphigus Foliaceus. Clinical and Experimental Dermatology, 2022; 47(1).
MESQUITA VNS, PIGARI VG. Abordagens terapêuticas no pênfigo vulgar: revisão da eficácia e segurança em pacientes adultos. Revista Eletrônica Acervo Saúde, 2025; 25 (5).
MOURA SEA, et al. Manifestações orais de doenças autoimunes: lúpus, pênfigo vulgar e líquen plano. Revista Íbero-Americana de Humanidades, Ciências e Educação (REASE), 2025; 11 (5).
MIYACHI H, et al. Clinical course and out comes of pemphigus vulgaris and foliaceus: A retrospective study using a Nationwide database in Japan. The Journal of Dermatology, 2022; 50.
REIS BS, et al. Pênfigo vulgar: revisão de literatura. Revista Multidisciplinar Humanidades e Tecnologias (FINOM), 2021; 30.
SOUZA MT, et al. Revisão integrativa: o que é e como fazer. Einstein (São Paulo), 2010; 8:102‑6
WELC N, et al. Clinical Characteristicis, Comorbidities, and Treatment in Patients with Pemphigus – A Single-Center Retrospective Study. Antibodies, 2024; 13(103).
